Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. - Todo T; Ito H; Ino Y; Ohtsu H; Ota Y; Shibahara J; Tanaka M (Nature medicine, 2025)